Elixinol Wellness (ASX:EXL) Other Long-Term Liabilities: A$1.52 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Elixinol Wellness Other Long-Term Liabilities?

Elixinol Wellness ASX:EXL -14.29% Other Long-Term Liabilities is A$1.52 Mil as of Dec. 2025. The stock has 7 warning signs investors should review.

Elixinol Wellness's other long-term liabilities for the quarter that ended in Dec. 2025 was A$1.52 Mil.

Elixinol Wellness's quarterly other long-term liabilities declined from Dec. 2024 (A$2.70 Mil) to Jun. 2025 (A$2.68 Mil) and declined from Jun. 2025 (A$2.68 Mil) to Dec. 2025 (A$1.52 Mil).

Elixinol Wellness's annual other long-term liabilities increased from Dec. 2023 (A$-0.00 Mil) to Dec. 2024 (A$2.70 Mil) but then declined from Dec. 2024 (A$2.70 Mil) to Dec. 2025 (A$1.52 Mil).

Elixinol Wellness Other Long-Term Liabilities Related Terms

Elixinol Wellness Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Elixinol Wellness's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elixinol Wellness Other Long-Term Liabilities Chart

Elixinol Wellness Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial 0.00 0.00 -0.00 2.70 1.52

Elixinol Wellness Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.10 2.70 2.68 1.52

Elixinol Wellness Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of A$1.52 Mil mean?
Elixinol Wellness (ASX:EXL) has a Other Long-Term Liabilities of A$1.52 Mil as of Dec. 2025. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Elixinol Wellness and its competitors.
Is Elixinol Wellness' Other Long-Term Liabilities too high?
Elixinol Wellness' current Other Long-Term Liabilities is A$1.52 Mil.
How does Elixinol Wellness' Other Long-Term Liabilities compare to ZTS and UTHR?
Elixinol Wellness' Other Long-Term Liabilities of A$1.52 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Drug Manufacturers company?
A good Other Long-Term Liabilities depends on the Drug Manufacturers industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Elixinol Wellness and its competitors. Elixinol Wellness's current Other Long-Term Liabilities is A$1.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elixinol Wellness stock overvalued right now?
Based on GuruFocus' analysis, Elixinol Wellness (ASX:EXL) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.01 — trading 70% below its estimated fair value. The current Other Long-Term Liabilities is A$1.52 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Elixinol Wellness (ASX:EXL), the current Other Long-Term Liabilities is A$1.52 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Elixinol Wellness Business Description

Other Exchanges ELLXF:USAE8M:Germany
Address 51 - 53 Riversdale Road, Newtown, VIC, AUS, 3220
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the three operating segments of the Americas, Australia, Rest of the World regions of which key revenue is derived from the Australia segment. The Australia segment includes the results from operations of Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries. It derives maximum revenue from Australia.